Laure Elens1, Elisabeth Norman, Maja Matic, Anders Rane, Vineta Fellman, Ron H N van Schaik. 1. *Department Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands; †Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium; ‡Unit of Pediatrics, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden; §Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet at Karolinska University Hospital, Huddinge, Stockholm, Sweden; and ¶Children's Hospital, University of Helsinki and Helsinki University Hospital, Finland.
Abstract
BACKGROUND: Single-nucleotide polymorphisms in genes involved in pain control might predispose to exaggerated sensitivity or difference in opioid analgesic effect. The relevance of the KCNJ6 -1250G>A (rs6517442, c.-1787G>A) and the catecholamine-O-methyltransferase (COMT) c.472G>A (rs4680, ValMet) single-nucleotide polymorphisms were studied in preterm infants needing intubation and randomized to a premedication strategy including remifentanil (n = 17) or morphine (n = 17). METHODS:Pain was scored with Astrid Lindgren and Lund Children's Hospital Pain Assessment Scale every 30 minutes for 6 hours. The pain relief provided by the opioids was compared between the different KCNJ6 and COMT genotypes. RESULTS:Infants homozygous for the KCNJ6 -1250A allele had an increased duration after intubation to achieve a score indicating no pain compared with infants with the A/G or G/G genotypes (182 ± 30, 109 ± 29, and 60 ± 21 minutes, respectively; Logrank = 7.5, P = 0.006). Similarly, the duration was increased in individuals with the COMT Val/Val alleles compared with Val/Met and Met/Met (285 ± 37, 137 ± 25, and 63 ± 15 minutes, respectively; Logrank = 14.4, P = 0.0021). Cox proportional hazards analysis confirmed that the variation in both genes was independently associated with susceptibility to respond to therapy. CONCLUSION: We conclude that the KCNJ6 -1250A and COMT Val alleles are predisposing preterm newborns to diminished opioid-induced pain relief.
RCT Entities:
BACKGROUND: Single-nucleotide polymorphisms in genes involved in pain control might predispose to exaggerated sensitivity or difference in opioid analgesic effect. The relevance of the KCNJ6 -1250G>A (rs6517442, c.-1787G>A) and the catecholamine-O-methyltransferase (COMT) c.472G>A (rs4680, ValMet) single-nucleotide polymorphisms were studied in preterm infants needing intubation and randomized to a premedication strategy including remifentanil (n = 17) or morphine (n = 17). METHODS:Pain was scored with Astrid Lindgren and Lund Children's Hospital Pain Assessment Scale every 30 minutes for 6 hours. The pain relief provided by the opioids was compared between the different KCNJ6 and COMT genotypes. RESULTS:Infants homozygous for the KCNJ6 -1250A allele had an increased duration after intubation to achieve a score indicating no pain compared with infants with the A/G or G/G genotypes (182 ± 30, 109 ± 29, and 60 ± 21 minutes, respectively; Logrank = 7.5, P = 0.006). Similarly, the duration was increased in individuals with the COMTVal/Val alleles compared with Val/Met and Met/Met (285 ± 37, 137 ± 25, and 63 ± 15 minutes, respectively; Logrank = 14.4, P = 0.0021). Cox proportional hazards analysis confirmed that the variation in both genes was independently associated with susceptibility to respond to therapy. CONCLUSION: We conclude that the KCNJ6 -1250A and COMTVal alleles are predisposing preterm newborns to diminished opioid-induced pain relief.
Authors: Emma C Johnson; Richard Border; Whitney E Melroy-Greif; Christiaan A de Leeuw; Marissa A Ehringer; Matthew C Keller Journal: Biol Psychiatry Date: 2017-07-13 Impact factor: 13.382
Authors: Cecil M Y Chau; Colin J D Ross; Vann Chau; Anne R Synnes; Steven P Miller; Bruce Carleton; Ruth E Grunau Journal: EBioMedicine Date: 2019-01-30 Impact factor: 8.143
Authors: Bram C Agema; Stijn L W Koolen; Mirjam de With; Nadia van Doorn; Niels Heersche; Esther Oomen-de Hoop; Sabine Visser; Joachim G J V Aerts; Sander Bins; Ron H N van Schaik; Ron H J Mathijssen Journal: Genes (Basel) Date: 2020-03-27 Impact factor: 4.096